BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7544562)

  • 1. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
    Lokeshwar BL; Lokeshwar VB; Block NL
    Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
    Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
    Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
    Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
    Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
    Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.
    Harn HJ; Ho LI; Yu CP; Wang MW; Lee HS; Lin JJ; Lee WH; Isola NR; Cooper DL
    Biochem Mol Biol Int; 1994 Feb; 32(2):233-8. PubMed ID: 7517252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
    Asplund T; Heldin P
    Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 isoforms in human prostate tumor cell lines.
    Stevens JW; Palechek PL; Griebling TL; Midura RJ; Rokhlin OW; Cohen MB
    Prostate; 1996 Mar; 28(3):153-61. PubMed ID: 8628718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
    Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells.
    Jamal HH; Cano-Gauci DF; Buick RN; Filmus J
    Oncogene; 1994 Feb; 9(2):417-23. PubMed ID: 7507229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD44 in human hepatocellular carcinoma cell lines.
    Haramaki M; Yano H; Fukuda K; Momosaki S; Ogasawara S; Kojiro M
    Hepatology; 1995 May; 21(5):1276-84. PubMed ID: 7537711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ; Rustgi AK
    Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 mediates human glioma cell adhesion and invasion in vitro.
    Merzak A; Koocheckpour S; Pilkington GJ
    Cancer Res; 1994 Aug; 54(15):3988-92. PubMed ID: 7518347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
    Dall P; Heider KH; Hekele A; von Minckwitz G; Kaufmann M; Ponta H; Herrlich P
    Cancer Res; 1994 Jul; 54(13):3337-41. PubMed ID: 7516819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.